Accessibility Statement Skip Navigation
  • Tilbake til globale nettsteder
  • +46 850741140
  • GDPR
  • Journalister
  • Be om mer informasjon
PR Newswire: news distribution, targeting and monitoring
  • Nyheter
  • Produkter
  • Kontakt
When typing in this field, a list of search results will appear and be automatically updated as you type.

Søke etter innhold...

Ingen resultater. Vennligst bruk avansert søk for å gjennomgå komplett sett med innhold.
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Be om mer informasjon
    • Telefon

    • +46 850741140 fra 8 AM - 5 PM GMT

    • Kontakt oss
    • Kontakt oss

      +46 850741140
      fra 8 AM - 5 PM GMT

  • When typing in this field, a list of search results will appear and be automatically updated as you type.

  • Be om mer informasjon
  • Journalister
  • GDPR
  • Be om mer informasjon
  • Journalister
  • GDPR
  • Be om mer informasjon
  • Journalister
  • GDPR
  • Be om mer informasjon
  • Journalister
  • GDPR

Study published in New England Journal of Medicine confirms universal decolonization of ICU patients reduces bloodstream infections by 44%


Nyheter levert av

Sage Products LLC

10 jun, 2013, 06:00 GMT

Del denne artikkelen

Share toX

Del denne artikkelen

Share toX

-- Patients' pathogen acquisition was reduced with Klorheksidin Baggerman 20 mg/ml impregnert pute and intranasal mupirocin ointment

CARY, Illinois, June 10, 2013 /PRNewswire/ -- The largest infection prevention study of its kind -- the Randomized Evaluation of Decolonization Versus Universal Clearance to Eliminate (REDUCE) MRSA -- found that using universal decolonization reduced MRSA clinical cultures by 37 percent and decreased bloodstream infections from any pathogen by 44 percent.

The study involved nearly 75,000 patients and more than 280,000 patient days in 74 adult ICUs located in 16 states. The results of the study demonstrate the effectiveness of chlorhexidine-impregnated pads to reduce bacteria that can cause infection.

The study was conducted in conjunction with investigators at Harvard, the U.S. Department of Health and Human Services agencies, the Agency for Healthcare Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC).

"These are often preventable infections that can cause serious complications for patients. These results are critical when assessing whether other measures, either targeted or universal, would have greater impact. The universal approach was clearly superior," said Dr. Robert Weinstein, a co-author of the study, professor of medicine at Rush University and chair of the Department of Medicine of John H. Stroger, Jr. Hospital, Chicago, Illinois, USA.

"The publication of this peer-reviewed, randomized controlled, multicenter study in a renowned journal provides compelling evidence to implement a comprehensive infection prevention protocol. The results of this CDC-funded and co-authored study validate our efforts to deliver the highest quality products to hospitals throughout Europe. We're committed to providing simple interventions that yield extraordinary outcomes," said Matthew Ross, vice president, International Business at Sage Products LLC.

Infection prevention is an essential part of healthcare today. About 1% to 2% of people carry MRSA on their skin or in their nose. When these patients are hospitalized, MRSA can enter their bloodstream during invasive procedures or spread to other patients on healthcare workers' hands. It's important to remember that universal decolonization reduces all bloodstream infections, not just MRSA.

For more information about Sage Products LLC, visit www.sageproductsglobal.com.

Modal title

Kontakt PR Newswire

  • +46 850741140
    fra 8 AM - 5 PM GMT

Globale nettsteder

  • APAC
  • APAC – Tradisjonell Kinesisk
  • Asia
  • Brasil
  • Canada
  • Czech
  • Danmark
  • Finland
  • Frankrike
  • Tyskland

 

  • India
  • Indonesia
  • Israel
  • Italia
  • Mexico
  • Midtøsten
  • Midtøsten - arabisk
  • Nederland
  • Norge
  • Polen

 

  • Portugal
  • Russland
  • Slovakia
  • Spania
  • Sverige
  • Storbritannia
  • Forente Stater

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Globale nettsteder
  • Asia
  • Brasil
  • Canada
  • Czech
  • Danmark
  • Finland
  • Frankrike
  • Tyskland
  • India
  • Israel
  • Italia
  • Mexico
  • Middle East
  • Nederland
  • Norge
  • Polen
  • Portugal
  • Russland
  • Slovakia
  • Spania
  • Sverige
  • Storbritannia
  • Forente Stater
+46 850741140
fra 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.